Though the regulations and labeling changed, Dairy Queen’s recipe never did. Now Dairy Queen’s soft serve qualifies as ...

A California couple that had 21 children via surrogacy has been charged with felony child endangerment and neglect.

Although Sarepta initially appeared to have avoided the worst possible outcome for Elevidys—market withdrawal—thanks to the gene therapy’s new black box warning, the FDA is signaling stronger ...

The 2000s were a mix of pop punk, flip phones, and drinks that gave you wings—and maybe a few bad decisions. While energy ...

The FDA determined the data from STARGLO did not provide sufficient evidence to support approving glofitamab-gxbm (Columvi) in combination with gemcitabine and oxaliplatin to treat relapsed/refractory ...

The drop comes the day after the drugmaker said it would add a so-called black-box warning to its gene therapy Elevidys after ...

The Food and Drug Administration has authorized Juul Labs to keep its e-cigarettes on the market, a major reversal after the agency completely banned the company’s products in 2022.

The analyst further reasoned that the high ocular toxicity rates, including keratopathy and visual acuity changes, are ...

The rollercoaster week for Sarepta Therapeutics continued, with shares of the embattled gene therapy-turned-siRNA biotech down 37% Friday afternoon as media outlets reported FDA plans to request a ...

In early research, OCU410ST, a gene therapy for Stargardt disease, demonstrated slowed lesion growth by 48% at the 12-month follow-up in evaluable treated eyes.

The restructuring enacted by Sarepta Therapeutics is expected to save up to $400 million in annual costs. Read why I'm ...

Milestone Pharmaceuticals' recent $52.5 million equity raise was poorly timed and dilutive, but it ensures its survival even ...